Description
NeuroElement™ — Multi-Target Brain Optimization Formulation
Inventor: Christopher Gabriel Brown
U.S. Patent Application No.: 19/555,525 — 24 claims
Filed: March 3, 2026 | Entity: Micro Entity (sole inventor)
Title of Invention: Multi-Element Neurotherapeutic Composition With Formulation Method and Computational Method for Designing Multi-Target Brain Disease Treatments
Status: Pending examination at the United States Patent and Trademark Office (USPTO). This is not a granted patent.
Priority chain: Prov. 63/552,008 (2024-02-09) → 18/650,137 (2024-04-30) → 19/031,884 (2025-01-18) → 19/177,547 (2025-04-12) → 19/555,525 (2026-03-03)
Research duration: ∼20 years
SKU: 2051 | Package ID: 22-brain-chemistry | Version: 1.0.0
Overview
NeuroElement is a patent-pending, computationally designed seven-compound brain-optimization formulation that delivers 10 of 14 brain-essential chemical elements through bioavailable, blood-brain-barrier-crossing forms. The formulation was designed using a proprietary algorithmic method that systematically analyses 54 diseases, 65 neurotransmitters, and 40 neurobiochemical mechanisms to identify the combination of elements with the highest combined mechanism-coverage and disease-coverage scores.
The deliverable is not a supplement bottle. It is the complete research-and-engineering source tree — Python analysis platform, structured JSON databases, formulation specification, dosing schedule, manufacturing notes, FDA-compliant Supplement Facts generator, CLI and REST-API tooling, and 7 research reports — everything required to evaluate, reproduce, manufacture, and commercialise the formulation.
Computational Method & Coverage Scores
The inventor constructed comprehensive databases covering 65 neurotransmitters, 20 brain-critical elements, 54 brain diseases (in 18 major categories), 40 identified neurobiochemical mechanisms, and 35 clinically approved brain medicines across four evolutionary categories. A six-step computational pipeline selects the element combination with the highest joint mechanism × disease score, then maps each element to a specific bioavailable delivery compound capable of crossing the blood–brain barrier.
Coverage summary
Metric Score
Neurobiochemical mechanisms addressed 34 / 40 (85 %)
Brain diseases with therapeutic relevance 16 / 18 (89 %)
Brain-essential elements delivered 10 / 14
Patent claims filed 24 (3 independent + 21 dependent)
The Seven-Compound Formulation
# Compound Chemical Formula Daily Dose Element Delivered Elemental Amount Key Mechanism
1 Magnesium L-Threonate C 8 H 14 MgO 10 1,000 mg (500 AM + 500 PM) Mg ∼96 mg NMDA modulation, glutamate regulation, ATP complexation, synaptic density
2 Zinc Carnosine C 9 H 12 N 4 O 3 Zn 75 mg (AM) Zn ∼16 mg BDNF signalling, NMDA modulation, amyloid regulation, >300 enzyme cofactor
3 Ebselen C 13 H 9 NOSe 300 mg (PM) Se ∼22 mg Glutathione peroxidase mimetic, IMPase inhibition (lithium mimetic), thyroid support
4 Pyridoxal-5′-Phosphate (P5P) C 8 H 10 NO 6 P 25 mg (AM) P ∼3.1 mg GAD cofactor (glutamate → GABA), serotonin & dopamine synthesis
5 Iron Bisglycinate C 4 H 8 FeN 2 O 4 25 mg (AM) Fe ∼5 mg Tyrosine hydroxylase cofactor (rate-limiting step of dopamine synthesis)
6 N-Acetyl-L-Cysteine (NAC) C 5 H 9 NO 3 S 600 mg (PM) S ∼60 mg Glutathione precursor, oxidative-stress defence, transition-metal chelation
7 Citicoline (CDP-Choline) C 14 H 26 N 4 O 11 P 2 500 mg (250 AM + 250 PM) P ∼108 mg Phospholipid membrane synthesis, acetylcholine precursor, neuroprotection
Daily total fill weight: 2,665 mg across 3 capsules (1 AM + 2 PM), Size 00 HPMC vegetarian shells
Elements Delivered to the Brain
Element Symbol Source Compound Daily Amount
Carbon C All 7 compounds Structural
Hydrogen H All 7 compounds Structural
Oxygen O All 7 compounds Structural
Nitrogen N All 7 compounds Structural
Magnesium Mg Magnesium L-Threonate ∼96 mg
Zinc Zn Zinc Carnosine ∼16 mg
Selenium Se Ebselen ∼22 mg
Phosphorus P P5P + Citicoline ∼111 mg
Iron Fe Iron Bisglycinate ∼5 mg
Sulfur S NAC ∼60 mg
Elements not covered: Cu, I, Mn, Cl — addressed in patent claims as optional additions.
Divided Dosing Schedule
Window Capsule Contents Fill Weight
Morning (AM) Capsule A (1 × Size 00) Magnesium L-Threonate 500 mg, Zinc Carnosine 75 mg, P5P 25 mg, Iron Bisglycinate 25 mg, Citicoline 250 mg, Excipients 85 mg 960 mg
Evening (PM) Capsule B1 (1 × Size 00) Magnesium L-Threonate 500 mg, Ebselen 300 mg, Excipients 30 mg 830 mg
Capsule B2 (1 × Size 00) NAC 600 mg, Citicoline 250 mg, Excipients 30 mg 880 mg
Key dosing rationale:
- Iron / NAC separation: Iron Bisglycinate (AM) and NAC (PM) are dosed 12 hours apart to prevent thiol chelation of Fe 2+ , which would reduce absorption of both compounds.
- Morning actives: P5P supports active-phase neurotransmitter synthesis (serotonin, dopamine). Iron supports dopaminergic tone during waking hours.
- Evening actives: Ebselen and NAC support glutathione regeneration during sleep-phase neurochemistry. Magnesium L-Threonate’s calming effect suits evening dosing (split AM/PM for steady-state).
Mechanism Coverage (34 / 40)
Mechanism Covered? By Component(s)
Neurotransmitter synthesis Yes Fe, P5P, Zn
Antioxidant Yes Se (Ebselen), S (NAC), Zn
Energy production Yes Mg, Fe, P
Ion channel Yes Mg, Zn
Synaptic transmission Yes Zn, Mg, Citicoline
Receptor modulation Yes Mg, Zn, Ebselen
Myelination Yes Fe
Structural Yes S (NAC), Citicoline
pH regulation Yes Mg
Oxidative stress Yes Se, S, Zn, Fe
Lipid signalling Yes Citicoline
Nitric oxide signalling Yes Fe, Ebselen
Circadian rhythm Yes P5P (melatonin synthesis)
Immune modulation Yes Zn, Se, Mg
Thyroid function Yes Se (deiodinase)
Gene expression Yes Zn (zinc-finger proteins)
Mitochondrial function Yes Fe, S (NAC), Mg
Protein structure Yes S (NAC), Zn
Redox regulation Yes Se, S, Fe
Neurotransmitter transport Yes Zn (DAT)
Neurotransmitter storage Yes Zn (vesicular)
Enzyme cofactor Yes Mg, Zn, Fe, P5P
Membrane integrity Yes Citicoline, S
Blood–brain barrier Yes Mg-Threonate
Excitotoxicity prevention Yes Mg, Zn (NMDA block)
Glutathione system Yes S (NAC), Se (Ebselen)
Dopamine pathway Yes Fe, Zn
Serotonin pathway Yes P5P, Fe
GABA pathway Yes P5P (GAD cofactor)
Acetylcholine pathway Yes Citicoline
Norepinephrine pathway Yes P5P
Homocysteine metabolism Yes P5P
Insulin signalling Yes Zn
Synaptic plasticity Yes Mg, Zn, Citicoline
Not covered (6): osmotic regulation, chloride channels, potassium channels, calcium signalling, cobalt / B12 pathway, manganese SOD — these rely on dietary elements (Na, Cl, K, Ca, Co, Mn) outside the formulation scope.
Disease Coverage Matrix (16 / 18)
Disease Mg-Thr Zn-Car Ebselen P5P Fe-Bis NAC Citicoline
Alzheimer’s Disease •• •• • •• — •• ••
Parkinson’s Disease • •• — •• •• •• •
Epilepsy •• • — •• — — —
Major Depressive Disorder • •• •• •• — — —
Bipolar Disorder • • •• — — — —
Schizophrenia • •• — •• — •• —
ALS • • — — • •• —
Huntington’s Disease • •• — — • •• —
Multiple Sclerosis — — — — •• •• —
ADHD — •• — • •• — —
Autism Spectrum Disorder • •• — • — — —
Generalised Anxiety •• • — •• — — —
Dementia (general) • •• — — — • ••
Migraine •• — — • — — —
Insomnia • — — •• — — —
Traumatic Brain Injury • — — — — •• ••
•• = primary mechanism | • = supporting mechanism | — = not directly addressed. Diseases not covered (2/18): Stroke (primarily vascular) and Brain Tumours (oncological).
Dopamine Assembly-Line Discovery
A key finding of the research is the Dopamine Assembly Line — a sequential metallic-cofactor pathway required for dopamine synthesis, conversion, and transport:
Step Element Enzyme Function
1 (rate-limiting) Iron (Fe 2+ ) Tyrosine Hydroxylase Converts L-Tyrosine → L-DOPA
2 Copper (Cu 2+ ) Dopamine Beta-Hydroxylase Converts Dopamine → Norepinephrine
3 Zinc (Zn 2+ ) Dopamine Transporter (DAT) Regulates synaptic dopamine reuptake
No existing Parkinson’s disease therapy supplies the metallic cofactors the dopamine assembly line requires. The NeuroElement formulation addresses steps 1 and 3 directly via Iron Bisglycinate and Zinc Carnosine; step 2 is supported by dietary copper.
Evolutionary Medicine Timeline (“Chicken or Egg” Discovery)
The database reveals that three independent timelines — evolutionary age , historical drug-discovery order , and pharmacokinetic onset speed — all converge on an identical ordering across four brain-medicine categories:
Rank Category Evolutionary Age Fastest Onset First Drug Discovered
1 Pain ∼500 million years 10 min (Sumatriptan SC) Morphine, 1804
2 Control (seizure/movement) ∼400 million years 30 min (Levodopa) Bromides, 1857
3 Delusional (psychosis/mood) ∼200–300 million years 20 min acute / 4–8 wk full (Haloperidol IM) Chlorpromazine, 1952
4 Memory Most recent 3–6 wk (Donepezil) / 6+ mo (Lecanemab) Tacrine, 1993
Principle: oldest brain system = fastest drug response = discovered first.
Database Statistics
Database Record Count Data File
Neurotransmitters 65 neurotransmitters.json
Brain-Critical Elements 20 brain_elements.json
Brain Diseases 54 (neurological 151–175, psychiatric 251–275, infections 17–20) brain_diseases.json
Symptom Observation Guides 54 (25 neurological + 25 psychiatric + 4 infection) symptom_observation_guide.json
Pharmaceutical Drug Entries 39 brain_elements.json (drug_book_entries)
Medicine Timeline (pharmacokinetics) 35 medicines across 4 categories medicine_timeline.json
Connected Research Projects
Project Description
07 — Alchemy Data V2 Foundation system — 36,456 compounds
10 — Diabetes Research 14 research compounds
11 — Alzheimer’s Research 14 research compounds (deep-dive)
12 — Parkinson’s Research 14 research compounds (patent filed)
13 — Disease Research 300 diseases, 36,456 compounds
Python Analysis Platform
The package ships a production-quality Python research platform (v1.0.0) requiring no dependencies beyond the standard library for CLI usage. An optional REST API layer uses FastAPI + Uvicorn.
Module File Purpose
brain_research __init__.py Package root — version 1.0.0
BrainChemistryDB brain_chemistry_db.py Master database — unified access to all neurotransmitter, disease, element, and observation data
BrainCompoundAnalyzer brain_compound_analyzer.py Core analysis engine — compound comparison, elemental mechanism mapping, disease-coverage scoring
NeurotransmitterDB neurotransmitter_db.py 65-neurotransmitter query engine with search, filtering, and cross-referencing
TimelineDB timeline_db.py Medicine pharmacokinetics and the “Chicken or Egg” evolutionary timeline analysis
SupplementFacts supplement_facts.py FDA-compliant Supplement Facts panel generator per 21 CFR 101.36
DiseaseExtractor disease_extractor.py Cross-project disease data extraction and unification
ReportGenerator report_generator.py Generates all 7 Markdown research reports from live data
DataLoader data_loader.py Singleton data loader with caching and full-text search indexing
Formatters formatters.py Output formatters — text, JSON, CSV
Config config.py Centralised paths, constants, connected-project registry
REST API api.py FastAPI application — /api/stats, search, compare, disease, timeline endpoints
CLI Tool brain_research_tool.py Full command-line interface — 14 sub-commands
Source Metric Count
Python source files 23
Total lines of Python 5,998
JSON data files 5 structured databases
Total lines of JSON 8,739
Test files (pytest) 5
Dependencies (core) 0 — standard library only
Optional dependencies FastAPI, Uvicorn, jsonschema, pytest
24 Patent Claims — Structure
Claim Type Claims Subject
Independent — Composition Claim 1 The 7-compound multi-element neurotherapeutic composition for oral administration, delivering ≥10 brain-essential elements
Dependent — Composition Claims 2–11 Dose ranges, divided-dosing regimen (AM/PM), capsule fill weights, excipients, mechanism coverage (≥30/40), disease coverage (≥10 diseases), ebselen as lithium mimetic, NAC as intra-composition safety, dopamine-pathway support, copper-exclusion rationale
Independent — Formulation Method Claim 12 Geometric-dilution pre-blend under reduced lighting (P5P photodegradation), two-stage blending, encapsulation
Dependent — Formulation Method Claims 13–15 Blending periods (5–10 min / 2 min), evening capsule preparation, QC testing (weight ±5 %, disintegration ≤30 min, moisture
Independent — Treatment Method Claim 16 Method of treating neurological or psychiatric disorders by administering the composition
Dependent — Treatment Method Claims 17–19 Disease list (16 diseases), divided-dose daily regimen (≥4 weeks), simultaneous coverage (≥30 mechanisms × ≥10 diseases)
Independent — Computational Method Claim 20 Eight-step algorithm: database construction → element mapping → mechanism scoring → disease scoring → combined scoring → BBB-compound selection
Dependent — Computational Method Claims 21–24 Sequential enzymatic dependencies (assembly-line identification), neurological/psychiatric molecular-weight classifier, minimum database sizes (≥40 diseases, ≥50 neurotransmitters, ≥30 mechanisms), specific BBB delivery-compound mappings
Research Documentation (7 Reports)
Report File Content
Brain Chemistry Master Report BRAIN_CHEMISTRY_MASTER_REPORT.md Full brain-chemistry overview, element roles, 10 drug categories, key principles
Neurotransmitter Reference NEUROTRANSMITTER_REFERENCE.md Complete reference of 65 brain neurotransmitters across 9 categories
Disease Cross-Reference BRAIN_DISEASE_MECHANISM_CROSS_REFERENCE.md Compound–disease mechanism overlap matrix
Compound Analysis COMPOUND_ANALYSIS_REPORT.md Chemical comparison of key research compounds (MW, electronegativity, mechanism counts)
Observation Diagnosis Guide OBSERVATION_DIAGNOSIS_GUIDE.md Observable symptoms for 54 diseases — identification by observation only
External Database Connections EXTERNAL_DATABASE_CONNECTIONS.md Links to PubChem, NIMH PDSP, HMDB, CSF Metabolome, StatPearls
Evolutionary Medicine Timeline EVOLUTIONARY_MEDICINE_TIMELINE.md The “Chicken or Egg” convergence analysis across 4 categories
Manufacturing Specification
Parameter Specification
Pre-blend method Geometric dilution — smallest component (P5P 25 mg) mixed 1:1 with MCC, then doubled progressively; reduced-lighting conditions to prevent P5P photodegradation
Blending periods First blend: 5–10 minutes; lubricant blend: 2 minutes (to avoid over-lubrication)
Capsule shell HPMC (hydroxypropyl methylcellulose), vegetarian, Size 00
Excipients Microcrystalline cellulose (MCC), magnesium stearate, silicon dioxide (SiO 2 )
Stability storage 15–25 °C,
GMP requirement Contract manufacturer must hold 21 CFR Part 111 (dietary supplement cGMP)
QC testing Identity, potency, heavy metals (USP / ), microbial limits (USP / ), capsule weight ±5 %, disintegration ≤30 min at 37 °C, moisture
Serving size 3 capsules/day (1 morning + 2 evening), 30 servings per container
Interaction Warnings
Interaction Detail
Iron + tea / coffee Tannins reduce iron absorption — take AM capsule 30 min before or 2 hr after
NAC + nitroglycerin NAC potentiates nitrate vasodilation — contraindicated with nitrate drugs
Ebselen + lithium Ebselen mimics lithium at IMPase — caution if patient is on lithium therapy
P5P + levodopa P5P can accelerate peripheral decarboxylation of L-DOPA — take separately from Parkinson’s medication (or use with carbidopa)
Zinc + copper Long-term Zn supplementation (>40 mg elemental) can deplete Cu — at 16 mg elemental, risk is low; monitor if taking >3 months
Competitive Landscape
Product Monthly Price Ingredients Patent? Mechanism Coverage
Qualia Mind $139–$159 28 No Not quantified
Alpha Brain $68–$80 11 No Not quantified
Mind Lab Pro ∼$69 11 No Not quantified
Prevagen $40–$90 1 active Yes (single ingredient) Single mechanism
Neuriva $28–$45 2 No Not quantified
NeuroElement™ $99–$129 7 compounds Yes — full formulation (19/555,525) 85 % (34/40)
MJFF Proposal & Collaboration
A formal pre-proposal letter was submitted on March 3, 2026 to The Michael J. Fox Foundation for Parkinson’s Research and to Dr. Mitesh Bhakta, PharmD (compounding pharmacist), outlining the Dopamine Assembly-Line discovery and requesting scientific evaluation and pharmaceutical compounding partnership.
What Is in the Package
Category Description
Total files 90 Complete 22-brain-chemistry/ source tree
Documentation Research reports, index, changelog, citation
Source code Python analysis platform, CLI, REST API, tests
Structured data JSON databases — neurotransmitters, elements, diseases, observations, timeline
Web Product description HTML, Supplement Facts preview, SVG generator
Other LICENSE, requirements.txt, shell scripts
Key deliverable artefacts:
- Formulation specification — product/formulation.md — complete 7-compound recipe with doses, rationale, excipients, capsule fill weights, and manufacturing notes.
- 5 structured JSON databases — neurotransmitters (65), brain elements (20), brain diseases (54), symptom observation guides (54), medicine timeline (35).
- Python research platform — 5,998 lines, 13 modules, 14 CLI sub-commands, REST API, test suite.
- 7 research reports — generated from live data, covering master overview, neurotransmitter reference, disease cross-reference, compound analysis, observation guide, external databases, and evolutionary timeline.
- FDA Supplement Facts generator — Python module generating a panel compliant with 21 CFR 101.36.
- Product valuation report — market analysis, competitive landscape, pricing strategy, IP valuation, revenue projections, acquisition scenarios.
- Data validation script — structural integrity checks and cross-reference validation for all JSON data.
How this is delivered
This package ships on a single Blu-ray disc, posted to the delivery address on your order. The archive on the disc is AES-256 encrypted; the passphrase is sent separately, by email, once the disc is despatched — so the disc alone is of no use to anyone who intercepts it.
Discs are despatched by tracked, signed-for post. Allow 5 business days for mastering and verification before despatch.
© 2026 Christopher Gabriel Brown. All rights reserved.
NeuroElement™ is a product designation of the inventor. U.S. Patent Application 19/555,525 — patent pending.
No intellectual property is conveyed with purchase. The underlying copyrighted material, the method-claim patent strategy, and the “Cri-One” and “NeuroElement” marks remain the property of Christopher Gabriel Brown.
Footnotes
- Product number 8470.
- Family: health research.
- Purchase: When you buy, you buy the use of that blueprint only.